RIGL vs. WELL
RIGL (Rigel Pharmaceuticals, Inc.) and WELL (Welltower Inc.) are both stocks. RIGL operates in Biotechnology (Healthcare), while WELL operates in REIT - Healthcare Facilities (Real Estate). Over the past 10 years, RIGL returned 3.28%/yr vs 15.50%/yr for WELL. At a 0.20 correlation, their price movements are largely independent.
Performance
RIGL vs. WELL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RIGL achieves a -23.30% return, which is significantly lower than WELL's 16.22% return. Over the past 10 years, RIGL has underperformed WELL with an annualized return of 3.28%, while WELL has yielded a comparatively higher 15.50% annualized return.
RIGL
- 1D
- 2.40%
- 1M
- 2.24%
- YTD
- -23.30%
- 6M
- -19.45%
- 1Y
- 54.23%
- 3Y*
- 27.10%
- 5Y*
- -3.96%
- 10Y*
- 3.28%
WELL
- 1D
- 1.69%
- 1M
- -2.68%
- YTD
- 16.22%
- 6M
- 15.53%
- 1Y
- 43.19%
- 3Y*
- 40.64%
- 5Y*
- 24.91%
- 10Y*
- 15.50%
RIGL vs. WELL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RIGL Rigel Pharmaceuticals, Inc. | -23.30% | 154.64% | 16.00% | -3.33% | -43.40% | -24.29% | 63.55% | -6.96% | -40.72% | 63.03% |
WELL Welltower Inc. | 16.22% | 49.86% | 43.07% | 41.79% | -21.18% | 36.98% | -17.19% | 23.04% | 15.31% | 0.22% |
Correlation
The correlation between RIGL and WELL is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2001 | 0.20 |
Fundamentals
RIGL:
$646.69M
WELL:
$155.59B
RIGL:
$19.21
WELL:
$2.02
RIGL:
1.71
WELL:
106.16
RIGL:
0.00
WELL:
2.35
RIGL:
2.08
WELL:
12.85
RIGL:
1.62
WELL:
3.55
RIGL:
$299.77M
WELL:
$11.63B
RIGL:
$279.95M
WELL:
$3.25B
RIGL:
$125.80M
WELL:
$3.00B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RIGL vs. WELL — Risk / Return Rank
RIGL
WELL
RIGL vs. WELL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rigel Pharmaceuticals, Inc. (RIGL) and Welltower Inc. (WELL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RIGL | WELL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.23 | ||
| Sortino ratioReturn per unit of downside risk | -1.02 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.34 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | 1.09 | 3.44 | -2.35 |
| Martin ratioReturn relative to average drawdown | 1.91 | 8.47 | -6.56 |
Loading charts...
Drawdowns
RIGL vs. WELL - Drawdown Comparison
The maximum RIGL drawdown since its inception was -99.37%, which is greater than WELL's maximum drawdown of -63.33%. Use the drawdown chart below to compare losses from any high point for RIGL and WELL.
Loading charts...
Drawdown Indicators
| RIGL | WELL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.37% | -63.33% | -36.04% |
Max Drawdown (1Y)Largest decline over 1 year | -50.08% | -12.61% | -37.47% |
Max Drawdown (3Y)Largest decline over 3 years | -57.75% | -12.99% | -44.76% |
Max Drawdown (5Y)Largest decline over 5 years | -85.24% | -40.78% | -44.46% |
Max Drawdown (10Y)Largest decline over 10 years | -86.40% | -63.33% | -23.07% |
Current DrawdownCurrent decline from peak | -96.93% | -2.68% | -94.25% |
Average DrawdownAverage peak-to-trough decline | -90.91% | -10.31% | -80.60% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.64% | 5.11% | +23.53% |
Volatility
RIGL vs. WELL - Volatility Comparison
Rigel Pharmaceuticals, Inc. (RIGL) has a higher volatility of 12.05% compared to Welltower Inc. (WELL) at 9.54%. This indicates that RIGL's price experiences larger fluctuations and is considered to be riskier than WELL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RIGL | WELL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.05% | 9.54% | +2.51% |
Volatility (6M)Calculated over the trailing 6-month period | 36.64% | 17.14% | +19.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 69.89% | 21.65% | +48.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 85.46% | 23.82% | +61.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 82.81% | 31.90% | +50.91% |
Dividends
RIGL vs. WELL - Dividend Comparison
RIGL has not paid dividends to shareholders, while WELL's dividend yield for the trailing twelve months is around 1.38%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RIGL Rigel Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
WELL Welltower Inc. | 1.38% | 1.52% | 2.03% | 2.71% | 3.72% | 2.84% | 4.18% | 4.26% | 5.01% | 5.46% | 5.14% | 4.85% |
Financials
RIGL vs. WELL - Financials Comparison
This section allows you to compare key financial metrics between Rigel Pharmaceuticals, Inc. and Welltower Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RIGL vs. WELL - Profitability Comparison
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
WELL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Welltower Inc. reported a gross profit of 0.00 and revenue of 3.35B. Therefore, the gross margin over that period was 0.0%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
WELL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Welltower Inc. reported an operating income of 752.32M and revenue of 3.35B, resulting in an operating margin of 22.4%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
WELL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Welltower Inc. reported a net income of 728.67M and revenue of 3.35B, resulting in a net margin of 21.7%.
Frequently Asked Questions
RIGL and WELL have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RIGL has higher volatility (12.05%) compared to WELL (9.54%). In terms of maximum drawdown, RIGL dropped -99.37% vs WELL's -63.33%.
WELL currently has the higher Sharpe Ratio (2.01 vs 0.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RIGL and WELL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer